SG11202000264TA - Removal of unbound drug after antibody drug conjugate coupling - Google Patents
Removal of unbound drug after antibody drug conjugate couplingInfo
- Publication number
- SG11202000264TA SG11202000264TA SG11202000264TA SG11202000264TA SG11202000264TA SG 11202000264T A SG11202000264T A SG 11202000264TA SG 11202000264T A SG11202000264T A SG 11202000264TA SG 11202000264T A SG11202000264T A SG 11202000264TA SG 11202000264T A SG11202000264T A SG 11202000264TA
- Authority
- SG
- Singapore
- Prior art keywords
- international
- product stream
- bold
- capillaries
- pct
- Prior art date
Links
- 239000000611 antibody drug conjugate Substances 0.000 title abstract 2
- 229940049595 antibody-drug conjugate Drugs 0.000 title abstract 2
- 230000008878 coupling Effects 0.000 title abstract 2
- 238000010168 coupling process Methods 0.000 title abstract 2
- 238000005859 coupling reaction Methods 0.000 title abstract 2
- 229940079593 drug Drugs 0.000 title abstract 2
- 239000003814 drug Substances 0.000 title abstract 2
- 238000000108 ultra-filtration Methods 0.000 abstract 4
- 239000012530 fluid Substances 0.000 abstract 3
- 239000003795 chemical substances by application Substances 0.000 abstract 2
- 238000005406 washing Methods 0.000 abstract 2
- 241000483002 Euproctis similis Species 0.000 abstract 1
- 238000006073 displacement reaction Methods 0.000 abstract 1
- 230000008520 organization Effects 0.000 abstract 1
- 238000000746 purification Methods 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
- B01D61/14—Ultrafiltration; Microfiltration
- B01D61/145—Ultrafiltration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
- B01D61/24—Dialysis ; Membrane extraction
- B01D61/243—Dialysis
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
- B01D61/24—Dialysis ; Membrane extraction
- B01D61/28—Apparatus therefor
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2311/00—Details relating to membrane separation process operations and control
- B01D2311/08—Specific process operations in the concentrate stream
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Water Supply & Treatment (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
- Peptides Or Proteins (AREA)
- External Artificial Organs (AREA)
- Medicinal Preparation (AREA)
- Treatment Of Liquids With Adsorbents In General (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17182039.2A EP3431168A1 (en) | 2017-07-19 | 2017-07-19 | Élimination de médicament non lié après couplage conjugué anticorps-médicament |
| PCT/EP2018/068970 WO2019016070A1 (en) | 2017-07-19 | 2018-07-12 | DISPOSAL OF NON-BOUND MEDICINAL PRODUCT AFTER CONJUGATED COUPLING MEDICINE-ANTIBODY |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202000264TA true SG11202000264TA (en) | 2020-02-27 |
Family
ID=59520721
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202000264TA SG11202000264TA (en) | 2017-07-19 | 2018-07-12 | Removal of unbound drug after antibody drug conjugate coupling |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20200206688A1 (ja) |
| EP (2) | EP3431168A1 (ja) |
| JP (1) | JP2020527102A (ja) |
| KR (1) | KR20200031134A (ja) |
| CN (1) | CN111093810A (ja) |
| AR (1) | AR112612A1 (ja) |
| AU (1) | AU2018304504A1 (ja) |
| BR (1) | BR112020001058A2 (ja) |
| CA (1) | CA3070113A1 (ja) |
| IL (1) | IL271949A (ja) |
| RU (1) | RU2020107296A (ja) |
| SG (1) | SG11202000264TA (ja) |
| TW (1) | TW201919747A (ja) |
| WO (1) | WO2019016070A1 (ja) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7474195B2 (ja) * | 2018-01-12 | 2024-04-24 | イミュノジェン， インコーポレイテッド | 抗体薬物のコンジュゲーション、精製、及び製剤のための方法 |
| EP3939691B1 (en) * | 2020-07-13 | 2023-11-22 | Sartorius Stedim Biotech GmbH | Device assembly for producing bioconjugates |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4670077B2 (ja) * | 2004-10-04 | 2011-04-13 | 独立行政法人産業技術総合研究所 | 生理活性高分子物質の精製方法及びその方法により得られる精製物 |
| IL308456A (en) * | 2005-04-08 | 2024-01-01 | Wyeth Llc | A multivalent pneumomuroral protein-polysaccharide conjugate preparation |
| CN101219846B (zh) * | 2008-01-23 | 2010-12-01 | 哈尔滨工业大学 | 超滤膜混凝/吸附/生物反应器一体化水深度处理方法及其装置 |
| EA025786B1 (ru) * | 2011-03-29 | 2017-01-30 | Иммуноджен, Инк. | Способ производства конъюгатов с улучшенной гомогенностью |
| US9650411B2 (en) * | 2012-08-07 | 2017-05-16 | Kyowa Hakko Kirin Co., Ltd. | Method of purifying protein |
| TWI596107B (zh) * | 2013-06-25 | 2017-08-21 | 卡地拉保健有限公司 | 單株抗體之新穎純化方法 |
| EP2907565A1 (de) * | 2014-02-17 | 2015-08-19 | Bayer Technology Services GmbH | Dialyse-Einheit zum kontinuierlichen Puffer- bzw. Medienaustausch aus einer Proteinlösung |
| JP6783767B2 (ja) * | 2014-12-22 | 2020-11-11 | アレクシオン ファーマシューティカルズ インコーポレイテッドＡｌｅｘｉｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． | 組換えタンパク質を精製する方法 |
| EP3015542A1 (de) * | 2015-05-07 | 2016-05-04 | Bayer Technology Services GmbH | Modulare anlage und verfahren zur kontinuierlichen, keimreduzierten produktion und/oder aufbereitung eines produktes |
-
2017
- 2017-07-19 EP EP17182039.2A patent/EP3431168A1/en not_active Withdrawn
-
2018
- 2018-07-12 RU RU2020107296A patent/RU2020107296A/ru unknown
- 2018-07-12 CA CA3070113A patent/CA3070113A1/en not_active Abandoned
- 2018-07-12 BR BR112020001058-8A patent/BR112020001058A2/pt not_active Application Discontinuation
- 2018-07-12 KR KR1020207004375A patent/KR20200031134A/ko not_active Application Discontinuation
- 2018-07-12 AU AU2018304504A patent/AU2018304504A1/en not_active Abandoned
- 2018-07-12 CN CN201880059650.XA patent/CN111093810A/zh active Pending
- 2018-07-12 EP EP18743719.9A patent/EP3655137A1/en not_active Withdrawn
- 2018-07-12 SG SG11202000264TA patent/SG11202000264TA/en unknown
- 2018-07-12 WO PCT/EP2018/068970 patent/WO2019016070A1/en unknown
- 2018-07-12 US US16/631,326 patent/US20200206688A1/en not_active Abandoned
- 2018-07-12 JP JP2020502328A patent/JP2020527102A/ja active Pending
- 2018-07-17 TW TW107124586A patent/TW201919747A/zh unknown
- 2018-07-19 AR ARP180102022 patent/AR112612A1/es unknown
-
2020
- 2020-01-09 IL IL271949A patent/IL271949A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AR112612A1 (es) | 2019-11-20 |
| CA3070113A1 (en) | 2019-01-24 |
| EP3431168A1 (en) | 2019-01-23 |
| BR112020001058A2 (pt) | 2020-07-14 |
| WO2019016070A1 (en) | 2019-01-24 |
| JP2020527102A (ja) | 2020-09-03 |
| EP3655137A1 (en) | 2020-05-27 |
| TW201919747A (zh) | 2019-06-01 |
| CN111093810A (zh) | 2020-05-01 |
| RU2020107296A (ru) | 2021-08-19 |
| US20200206688A1 (en) | 2020-07-02 |
| AU2018304504A1 (en) | 2020-01-30 |
| KR20200031134A (ko) | 2020-03-23 |
| IL271949A (en) | 2020-02-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11201809912UA (en) | Hybrid carriers for nucleic acid cargo | |
| SG11201807912SA (en) | Vaccine against rsv | |
| SG11201811807XA (en) | Dairy product and process | |
| SG11201810600WA (en) | Fxr (nr1h4) modulating compounds | |
| SG11201811431VA (en) | Multispecific antibodies against cd40 and cd137 | |
| SG11201809344QA (en) | Process for synthesizing 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)-pyridin-3-yl)methoxy)benzaldehyde | |
| SG11201909960UA (en) | Methods for improving memory and cognition and for treating memory and cognitive disorders | |
| SG11201808622SA (en) | Chimeric receptors to flt3 and methods of use thereof | |
| SG11201909506WA (en) | Intravascular blood pump with balloon | |
| SG11201807827VA (en) | Process for the preparation of pegylated drug-linkers and intermediates thereof | |
| SG11201909011PA (en) | Niraparib compositions | |
| SG11201907208XA (en) | Radiolabeled anti-lag3 antibodies for immuno-pet imaging | |
| SG11201907804QA (en) | Pharmaceutical composition comprising selexipag | |
| SG11201808108XA (en) | Synthesis of indazoles | |
| SG11201809830WA (en) | Selective reduction of cysteine-engineered antibodies | |
| SG11201808686VA (en) | Synthesis of indazoles | |
| SG11201804143WA (en) | A process and apparatus for in-line blending of polymers | |
| SG11201808539WA (en) | Mouth piece for cooling of oral tissue of a patient during chemotherapy treatment | |
| SG11202000333UA (en) | Bicyclic ketone compounds and methods of use thereof | |
| SG11201909807TA (en) | Methods of manufacturing of niraparib | |
| SG11201909680UA (en) | Phenyl-2-hydroxy-acetylamino-2-methyl-phenyl compounds | |
| SG11201810801QA (en) | Brain delivery protein | |
| SG11201909003YA (en) | Integrated vascular access device and anchor pad | |
| SG11201807523PA (en) | Ilt7 binding molecules and methods of using the same | |
| SG11201804821PA (en) | A beverage capsule |